Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-29T02:51:24.992Z Has data issue: false hasContentIssue false

C.3 Development and validation of a prediction model for perinatal arterial ischemic stroke in term neonates

Published online by Cambridge University Press:  05 June 2023

R Srivastava
Affiliation:
(Edmonton)*
M Dunbar
Affiliation:
(Calgary)
M Shevell
Affiliation:
(Montreal)
M Oskoui
Affiliation:
(Montreal)
A Basu
Affiliation:
(Newcastle upon Tyne)
M Rivkin
Affiliation:
(Boston)
E Shany
Affiliation:
(Beer-Sheva)
L de Vries
Affiliation:
(Utrecht)
D Dewey
Affiliation:
(Calgary)
N Letourneau
Affiliation:
(Calgary)
MD Hill
Affiliation:
(Calgary)
A Kirton
Affiliation:
(Calgary)
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Background: Perinatal arterial ischemic stroke (PAIS) is a focal brain injury in term neonates, identified postnatally but presumed to occur around birth. Early risk detection and targeted treatments are limited. We developed and validated a diagnostic risk prediction model from common clinical factors to predict a term neonate’s probability of PAIS. Methods: A diagnostic prediction model was developed using multivariable logistic regression. Common pregnancy, delivery, and neonatal clinical factors were collected across four registries. Variable selection was based on peer-reviewed literature. Participant inclusion criteria were term birth and no underlying predisposition to stroke. The primary outcome was discriminative accuracy of the model predicting PAIS, measured by the concordance (C-) statistic. Results: 2571 participants (527 cases, 2044 controls) were eligible for analysis. Nine variables were included in the model – maternal age, tobacco exposure, recreational drug exposure, pre-eclampsia, chorioamnionitis, maternal fever, emergency c-section, low 5-minute Apgar score, and sex – to predict the risk of PAIS in a term neonate. This model demonstrated good discrimination between cases and controls (C-statistic 0.73) and model fit (Hosmer-Lemeshow p=0.20). Conclusions: Clinical variables can be used to develop and internally validate a model of PAIS risk prediction. Identifying high-risk neonates for early screening and treatment could reduce lifelong morbidity.

Type
Abstracts
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of Canadian Neurological Sciences Federation